Better Leukemia Diagnostics Through AI (BELUGA)

RecruitingOBSERVATIONAL
Enrollment

25,000

Participants

Timeline

Start Date

January 5, 2020

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
Hematologic MalignancyLeukemiaMinimal Residual DiseaseLymphomaBlood Cancer
Interventions
DIAGNOSTIC_TEST

Automated AI-Guided Diagnosis of Hematological Malignancies

In BELUGA, we want to investigate whether the automated analysis of blood (from peripheral blood and bone marrow aspirates) smears and flow-cytometry-based analyses can provide a benefit for diagnostic quality and, ultimately, patient care.

Trial Locations (1)

81377

RECRUITING

MLL Munich Leukemia Laboratory, Munich

All Listed Sponsors
lead

Munich Leukemia Laboratory

INDUSTRY